GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » Gross Profit

QUIA PHARMA AB (OSTO:QUIA) Gross Profit : kr2.72 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB Gross Profit?

QUIA PHARMA AB's gross profit for the six months ended in Dec. 2024 was kr0.46 Mil. QUIA PHARMA AB's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was kr2.72 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. QUIA PHARMA AB's gross profit for the six months ended in Dec. 2024 was kr0.46 Mil. QUIA PHARMA AB's Revenue for the six months ended in Dec. 2024 was kr0.00 Mil. Therefore, QUIA PHARMA AB's Gross Margin % for the quarter that ended in Dec. 2024 was %.

QUIA PHARMA AB had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of QUIA PHARMA AB was 115.42%. The lowest was -160.56%. And the median was 54.69%.


QUIA PHARMA AB Gross Profit Historical Data

The historical data trend for QUIA PHARMA AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB Gross Profit Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.99 0.31 3.33 4.37 0.46

QUIA PHARMA AB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.07 0.74 2.63 2.26 0.46

Competitive Comparison of QUIA PHARMA AB's Gross Profit

For the Biotechnology subindustry, QUIA PHARMA AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QUIA PHARMA AB's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's Gross Profit falls into.


;
;

QUIA PHARMA AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

QUIA PHARMA AB's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=0 - -0.46
=0.46

QUIA PHARMA AB's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=0 - -0.46
=0.46

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr2.72 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

QUIA PHARMA AB's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.46 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


QUIA PHARMA AB  (OSTO:QUIA) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

QUIA PHARMA AB had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


QUIA PHARMA AB Gross Profit Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


QUIA PHARMA AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines